Wednesday, November 28, 2012

Thyroid Follicular Cancer Treatment







Thyroid follicular cancer is a disease that usually occurs after the age of 40. Nearly 99 percent of those who receive thyroid follicular cancer treatment in the early stages of the cancer will live for at least 5 years. The decade-long survival rate approaches 40 percent.


Identification


Thyroid tissue is comprised of follicular cells and parafollicular cells. "Most of the thyroid tissue consists of the follicular cells, which secrete iodine-containing hormones called thyroxine (T4) and triiodothyronine (T3)," according to The University of Maryland Medical Center.


Significance


After papillary, follicular thyroid cancer is the second-most common form of the disease. It constitutes approximately 15 to 25 percent of cases.


Types of Treatment








Non-invasive forms of thyroid follicular cancer treatment include oral consumption of radioactive iodine or chemotherapy medication designed to kill cancerous cells. Additionally, external radiation therapy may be used to beam radiation from a machine directly onto the thyroid.


Surgery


Should these options fail to place the cancer into remission, removal of the thyroid gland (thyroidectomy) will be necessary. There is some controversy as to whether total or partial removal of the gland is necessary. Most physicians prefer to err on the side of caution and extract the entire thyroid.


Considerations


Those who undergo a thyroidectomy will need to receive hormone replacement therapy for life. "The goal of thyroid hormone treatment is to closely replicate normal thyroid functioning," says The American Thyroid Association. This is achieved through daily consumption of a small pill.

Tags: cancer treatment, follicular cancer, follicular cancer treatment, follicular cells, thyroidectomy will